MoneyWorks4Me

Lupin informs about press release

30 Dec 2016 Evaluate

Lupin has informed about a Press Release dated December 30, 2016, titled ‘Lupin Receives Tentative Approval for Generic Livalo Tablets’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2109.95 -25.05 (-1.17%)
04-Sep-2026 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.90
Dr. Reddys Labs. 1157.60
Cipla 1380.50
Lupin 2109.95
Zydus Lifesciences 1130.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: